NCT07906340
Magnesium Kinetics During Citrate-Anticoagulated CRRT
At risk: Primary endpoint(s) modified.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary endpoint(s) modified
- Start date pushed from Oct 2026 to Nov 2026
- Secondary endpoints: 3 to 10
- Eligibility criteria expanded, about 5 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Changes in systemic total magnesium concentration
Timeframe: Before CRRT initiation (baseline) and at 2, 6, 12, 18, 24, 48, and 72 hours after initiation.
Changes in systemic ionized magnesium concentration
Timeframe: Before CRRT initiation (baseline) and at 2, 6, 12, 18, 24, 48, and 72 hours after initiation.
Citrate-associated changes in magnesium ionization
Timeframe: At 2, 6, 12, 18, 24, 48, and 72 hours after CRRT initiation.
Magnesium flux across the extracorporeal filter
Timeframe: At 2, 6, 12, 18, 24, 48, and 72 hours after CRRT initiation.
Net magnesium loss attributable to CRRT
Timeframe: At 2, 6, 12, 18, 24, 48, and 72 hours after CRRT initiation.
Secondary (10)
Changes in systemic total calcium concentration
Changes in systemic ionized calcium concentration
Calcium flux across the extracorporeal filter
Net calcium loss attributable to CRRT
Changes in systemic phosphate concentration
Show 5 moreShow less
Phosphate flux across the extracorporeal filter
Net phosphate loss attributable to CRRT
Changes in systemic blood pH during RCA-CRRT
Changes in systemic bicarbonate concentration during RCA-CRRT
Changes in systemic base excess during RCA-CRRT
Arms and interventions
Other: Serial blood and dialysis circuit fluid sampling